John Cush/rheumnow.com
Jan 11, 2026, 06:59
John Cush: Subcutaneous Anifrolumab Effective in Lupus
John Cush, Executive Editor at RheumNow.com, shared a post on LinkedIn:
“Subcutaneous Anifrolumab Effective in Lupus
A new study published in Arthritis and Rheumatology demonstrates that subcutaneous administration of anifrolumab provides efficacy comparable to intravenous administration, offering a promising alternative for at-home care of patients living with moderate-to-severe SLE.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 14, 2026, 15:14This Month’s F and S On Air Podcast Is Out Now – Fertility and Sterility
-
Apr 14, 2026, 14:51Lydia Akpan: Key Signs of Oocyte Dysmorphism
-
Apr 14, 2026, 14:42Emre Göksan Pabuçcu: Honored to Speak at the 12th National Gynecological Endoscopy Congress
-
Apr 14, 2026, 14:36Shivam Rathore: Why Temperature and Humidity Control in IVF Labs is Non-Negotiable?
-
Apr 14, 2026, 14:29Yannick Hurni: Attending SEUD 2026 Has Been a Powerful Reminder of What Conferences Truly Represent
-
Apr 14, 2026, 14:26Maria Cristina Sangiovanni: Honored to Have Spoken at the 12th SEUD Congress in Frankfurt!
-
Apr 14, 2026, 14:21Nikolaos Polyzos: What Will Reproductive Medicine Look Like in 10 Years?
-
Apr 14, 2026, 14:16Xavier Carcopino: Early and Organized HPV Vaccination Saves Lives
-
Apr 14, 2026, 12:52Ting Yuan: Using Endometrial Immune Profiling in Young IVF Patients